Table 4 Healthcare resource utilization costs at 6, 12, and 24 months
Outcome | 6 months | 12 months | 24 months | ||||||
|---|---|---|---|---|---|---|---|---|---|
Cabazitaxel | Second ARTA | Difference | Cabazitaxel | Second ARTA | Difference | Cabazitaxel | Second ARTA | Difference | |
SSEs | $219,191 (€186,312) | $309,285 (€262,892) | −$90,094 (−€76,580) | $394,870 (€335,640) | $519,906 (€441,920) | −$125,036 (−€106,281) | $566,887 (€481,854) | $674,083 (€572,971) | −$107,196 (−€91,117) |
AEs | $226,750 (€192,738) | $202,843 (€172,417) | $23,907 (€20,321) | $267,456 (€227,338) | $234,821 (€199,598) | $32,635 (€27,740) | $277,018 (€235,465) | $256,140 (€217,719) | $20,878 (€17,746) |
End-of-life care | $181,617 (€154,374) | $248,254 (€211,016) | −$66,637 (−€56,641) | $569,678 (€484,226) | $722,550 (€614,168) | −$152,872 (−€129,941) | $982,563 (€835,179) | $1,189,006 (€1,010,655) | −$206,443 (−€175,477) |
Total | $627,559 (€533,425) | $760,382 (€646,325) | −$132,823 (−€112,900) | $1,232,003 (€1,047,203) | $1,477,277 (€1,255,685) | −$245,274 (−€208,483) | $1,826,468 (€1,552,498) | $2,119,229 (€1,801,345) | −$292,761 (−€248,847) |